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The probabilistic behavior of direct induction of
pluripotency has been a subject of intense research
interest. Here we discuss recently published reports on
this topic.A more extended period of tracking monoclonal re-Induced pluripotent stem cells (iPSCs) can be generated
from somatic cells by ectopic expression of different
pluripotency-promoting transcription factors, canonic-
ally Oct4, Sox2, Klf4 and Myc (abbreviated as OSKM)
[1]. Exogenous elements involved in signaling and chro-
matin modification, such as inhibition of ERK and GSK3
signaling (known as ‘2i’ conditions), Lif/Stat3 signaling
and/or inclusion of ascorbic acid-containing supple-
ments, directly participate in the reactivation of the en-
dogenous pluripotency circuitry by OSKM [2]. However,
OSKM reprogramming is a relatively inefficient process
in which only a small minority of somatic donor cells
become reprogrammed after an initial period of 10 to 14
days (0.1% to 15% efficiency) [3]. A number of recent
studies have sought to better understand the nature of
this inefficiency, and how it might be overcome [4-6].Characterizing iPSC reprogramming dynamics
A comprehensive investigation of the first 12 days of
mouse embryonic fibroblast (MEF) reprogramming by
time-lapsed live microscopy allowed the tracking of sin-
gle early committing founder cells throughout their
rapid conversion to iPSCs [7]. This approach highlighted
the characteristics of the small fraction of donor cells
(up to 3%) that rapidly undergo an early iPSC commit-
ment event, which can occur as early as the first cell div-
ision after induction. The clonal reprogramming of the
entire cell progeny of these founder cells is detected 7 to
14 days later. Different donor somatic cell types (kerati-
nocytes, pro-B cells or neural progenitor cells, for ex-
ample) yield different efficiencies for early committing* Correspondence: jacob.hanna@weizmann.ac.il
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unless otherwise stated.iPSCs after 7 days of OSKM induction (Figure 1a). These
differences are possibly due to a variety of determinants,
such as cell-type differences in endogenous expression
of pluripotency-promoting factors (Sox2 and Klf family
members) or reduced tendency for oncogene-induced
senescence following OSKM induction.
programming dynamics (up to 18 weeks) in pro-/pre-B
cell populations that did not yield iPSCs in the first 14
day period, and yet continued to expand, indicated that
these populations can eventually give rise to daughter
cell iPSCs at unpredicted latency [3]. Importantly, even
when starting with homogenous donor cell populations
and inducing a relatively more optimized OSKM stoichi-
ometry, whether an individual donor somatic cell will
follow an early committed reprogramming trajectory
(termed as ‘privileged’ by Guo et al. [4] - see next sec-
tion) or a protracted asynchronized conversion is ran-
dom and cannot be a priori and definitively predicted
based on surface markers, cell cycle phase or other iden-
tifiable parameters in the original donor cells [3].
A number of studies have attempted to define patterns
of cell surface antigens present in those donor cells com-
mitted to a reprogramming trajectory [8]. However, al-
though these markers may increase the probability of
identifying committed reprogramming intermediates,
they are not a definite guarantee for iPSC progression at
the single cell level. Another approach utilized cutting
edge methods for single cell gene expression analysis at
multiple time points during 1 to 3 weeks of MEF repro-
gramming, and identified specific endogenous expres-
sion hierarchies as predictive markers for increased
probability of overcoming the restraining element(s) ren-
dering this process stochastic - and hence of entering
the committed hierarchical phase leading to iPSC repro-
gramming completion [9]. Yet again, although such
markers are suitable for identifying cells that have over-
come these restraining element(s), they are not necessar-
ily predictive of the probabilistic trajectory assumed at
the single donor cell level upon OSKM induction.
A conceptually different approach presented by our
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Figure 1 Energy landscape models for iPSC reprogramming. (a) Illustration of the energy landscape experienced by cells under
reprogramming conditions. The funnel-like energy landscape represents the path from somatic cell states (for example, MEF and GMP) at the
boundaries of the funnel, to the pluripotent state at the middle lowest energy point. (b) Energy plot of the path from MEF to iPSC under different
epigenetic perturbations. The black line represents the energy landscape experienced by wild-type MEFs. The red line represents the energy
landscape experienced by Mbd3-depleted (Mbd3low) MEF donor cells. This depletion reduces energy barriers and accelerates reprogramming by
OSKM to a near-deterministic process. Notably, imposed barriers can occur by depletion of non-rate-limiting essential factors, such as Utx and
Wdr5 epiegentic reegulators, whose depletion inhibits and impairs the reactivation of pluripotency genes by OSKM, as marked by the imposed
dashed black line barriers [2]. (c) Energy plot of the path from MEF (black line) or GMP (blue line) states to the iPSC state. Energy peaks represent
barriers in the reprogramming path, where higher barriers correspond with low conversion rates. Different cell types experienced different
barrier landscapes [4]. GMP, granulocyte monocyte progenitor; iPSC, induced pluripotent stem cell; MEF, mouse embryonic fibroblast; Mbd3,
methyl-CpG-binding domain protein 3; OSKM, Oct4, Sox2, Klf4 and Myc.
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synchronized approach, and from multiple donor cell types,
by dismantling epigenetic repressors that hamper the rapid
reactivation of endogenous pluripotency genes. Indeed, de-
pletion of the methyl-CpG-binding domain protein 3
(Mbd3) co-repressor coupled with naïve pluripotencyconditions (supplemented with 2i/Lif and ascorbic acid)
synergistically facilitated up to 100% synchronized iPSC for-
mation from a variety of mouse cells (including MEFs,
neural progenitor cells and pro-/mature B cells) following
adequate OSKM induction [2] (Figure 1b). This approach
also proved successful with in vitro differentiated human
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human naïve pluripotency conditions.
A recent study by Guo et al. [4] reported ‘privileged’
granulocyte monocyte progenitor cells (GMPs) that ex-
hibit ‘nonstochastic’ reprogramming, where up to 20%
of freshly isolated cells retain a highly proliferative state
and convert rapidly into iPSCs within 5 to 10 days of
OSKM induction. Another study indicated that a short
pulse with the transcription factor CCAAT/enhancer-
binding protein-α (C/EBPα) in mouse pro-/pre-B cells
could lead to their rapid and poised induction to pluri-
potency by OSKM within up to 8 days in 2i/LIF- and as-
corbic acid-containing conditions [5]. But how do these
important findings complement and fit into the rapidly
evolving framework for reprogramming dynamics and
its molecular regulation?
‘Privileged’ somatic cells or ‘just lucky’ iPSCs?
In order to set the scene for the discussion of ‘privileged’
somatic cell subpopulations, a simple example can be
given. Assuming we ask a population of poker players to
draw and reveal their first hand of five cards, some of
these players may have a full house as a first hand (des-
pite the low probability of this event). Are they privi-
leged poker players or just lucky?
Guo et al. [4] elegantly showed that when challenging
freshly isolated and highly proliferative GMPs with
OSKM, a subpopulation of 10% to 20% exhibits fast re-
programming with almost uniform progeny conversion
to pluripotency (Figure 1a,c). The authors attribute this
behavior to the rapid proliferative state of GMPs (8-h
cell division rate). They also showed that when these
cells were expanded in vitro under low proliferating con-
ditions, the percentage of privileged reprogramming-
derived cells decreased dramatically from the same som-
atic cell state. Hematopoietic stem cell progenitors
(lineage-negative c-Kit-positive Sca-1-positive (LKS) cells),
which are less differentiated than GMPs, reprogram at
lower efficiency than freshly isolated GMPs, thus refuting
previous claims that the differentiation state per se is a
critical determinant in reprogramming. Instead, important
technical parameters, such as proliferation rate, can alter
the outcome of iPSC reprogramming. It is important to
note that privileged reprogramming, where commitment
occurs early and randomly after overcoming the main bar-
rier(s), is not restricted to GMPs, and is observed in other
somatic cells, such as LKS cells and MEFs, albeit at much
lower efficiency [4]. These results corroborate previously
published studies on tracking reprogramming early after
OSKM induction by live video imaging [7].
Intriguingly, Guo et al. [4] used the term ‘nonstochas-
tic’ to describe the ‘privileged’ reprogramming trajectory
assumed by GMPs. However, in our opinion, the results
presented do not support deterministic behavior at theGMP donor cell population level. In contrast to the
spectrum of stochastic behaviors described before, a
nonstochastic or deterministic behavior is very strin-
gently defined and dictates synchronized reprogramming
of all donor cells and their progeny with a fixed latency
immediately following OSKM induction. However, none
of the examined cell populations showed nonstochastic
or deterministic reprogramming dynamics where near
100% of donor cells had synchronized reprogramming
efficiency [4]. Whether a single cell from a GMP
population adopted a ‘privileged’ or protracted trajec-
tory remained stochastic, with a 10% to 20% chance
of following the privileged route.
Even when Guo et al. [4] sorted GMPs into slow- and
fast-dividing subpopulations, the latter showed only a
slight increase in reprogramming efficiency (from 2% to
6%). The fact that fast-dividing GMPs in general have a
higher probability of ‘privileged’ reprogramming than
slow dividing GMPs, or other donor cell types, does not
render reprogramming by OSKM in these cells nonsto-
chastic because one cannot a priori definitively predict
the trajectory of an individual GMP cell from the start-
ing purified cell population [2]. The fast dividing GMPs
appear to have stochastic reprogramming but with
higher probability to commit early to the process, pos-
sibly due to the accelerated cell cycle. Indeed, the quan-
titative change in iPSC reprogramming could be
explained by the threefold acceleration of the cell cycle
in the fast dividing cells [4].
Importantly, Guo et al. tested whether increasing the
cell cycle rate of LKS donor cells increased the probabil-
ity of adopting a ‘privileged’ iPSC reprogramming trajec-
tory. Cytokine-stimulated ultra-fast dividing LKS donor
cells acquired monoclonal ‘privileged’ reprogramming ef-
ficiency of 3.6% (a greater than tenfold increase relative
to slow proliferative conditions). Still, the majority of the
donor LKS cell population, even under highly prolifera-
tive conditions, did not undergo ‘privileged’ reprogram-
ming following OSKM induction; whether rapid early
commitment occurred in a clonal population from rap-
idly proliferating OSKM-challenged LKS cells was ran-
dom (with a probability of 3.6%).
Reprogramming and cell cycle dependency
Increasing the cell cycle by genetic manipulation can ac-
celerate reprogramming dynamics [3]. This acceleration
is proportional to the cell cycle change and relates to the
increased number of cell divisions during the repro-
gramming process. Guo et al. [4] showed that after 6
days of OSKM induction in MEF cells, a small subpopu-
lation (0.8%) of fast-dividing cells appears that accounts
for almost all reprogrammed iPSCs detected early in re-
programming. These results are consistent with the
identification of a fast-dividing subpopulation as an early
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which has an increased probability of finishing the con-
version to pluripotency. Importantly, however, this fast-
dividing subpopulation, characterized as ‘privileged’ [4],
is stochastically induced after 6 days of OSKM induc-
tion, and is not present in donor MEFs prior to OSKM
induction. Hence, these cells can be defined as ‘lucky’
cells that underwent commitment towards iPSCs and as-
sumed the accelerated cell cycle typical of pluripotent
cells. However they cannot amount to nonstochasticity,
as they are randomly induced after OSKM expression.
Further, applying the term ‘privileged somatic cells’ to
MEF cells that have undergone OSKM for 6 days is con-
troversial, given that several studies have shown that
early iPSCs can already be obtained at this time [2,8].
The authors went on to show that p53 knockdown in-
creases the fast-dividing subpopulation after 6 days of
OSKM, allowing for a larger fraction of cells to become
fully reprogrammed (1.6%). The authors concluded that
a rapid cell cycle state endows the cells with greater
competence to assume a ‘privileged’ reprogramming
route following OSKM induction. However, these results
could alternatively be explained by the twofold cell cycle
rate increase caused by p53 depletion, which increases
the rate of conversion to the first intermediate of fast
dividing cells and so may underlie the twofold increase
in reprogramming efficiency observed by Guo et al. [4].
In summary, the mechanistic basis for the dependency
between reprogramming efficiency and cell cycle rates is
not yet understood and constitutes an important direc-
tion for further mechanistic research.
Cell type-specific poising for rapid
reprogramming
Di Stefano et al. [5] elegantly revisited previous studies
that employed overexpression of C/EBPα to boost
mouse B-cell reprogramming to iPSCs by OSKM. The
authors devised an 18-h pulse of C/EBPα expression
followed by OSKM induction in mouse pro-/pre-B cells
as a means to achieve rapid reactivation of the Oct4-
GFP pluripotency reporter in up to 60% of the donor
population within 8 days. When adding 2i and ascorbic
acid supplements, the efficiency increased to 95%. C/
EBPα expression was accompanied by induction and nu-
clear translocation of tet methylcytosine dioxygenase 2
(Tet2), which converts methylcytosine to hydroxy-
methylcytosine, and an increased chromatin accessibility
of endogenous pluripotency genes [5].
The above results are intriguing and provide further
support for the feasibility to render the reprogramming
process near deterministic [2]. Several interesting ques-
tions relating to C/EBPα's role remain to be identified.
First, its enhancing effect is specific to pre-/pro-B cells -
this is absent even in more mature B cells, T-cellprogenitors and MEFs [2]. A mechanistic explanation re-
mains to be fully defined, as Tet2 induction is unlikely
to be the only cause for the observed dramatic change in
reprogramming kinetics, since Tet2 depletion leads to a
very mild reduction in iPSC reprogramming of somatic
cells by OSKM. Whether the Mbd3/nucleosome remod-
eling and deacetylase (NuRD) complex or other co-
repressor complexes are perturbed following this repro-
gramming strategy remains to be tested. Finally, extra
caution should be taken when conducting and quantify-
ing iPSC reprogramming from hematopoietic cells, as
mouse embryonic stem cell culture conditions are not
compatible with hematopoietic cell survival and can arti-
ficially bias selection for early reprogrammed cells, in-
creasing their relative fraction rather than their absolute
number. Indeed, Di Stefano et al. indicated that OSKM
induction along with their pluripotent reprogramming
conditions rapidly depleted nonreprogrammed cells [5].
It may be advisable to routinely exclude cell death and
biases in somatic cell survival as the predominant causes
for increased reprogramming efficiencies in any future
studies, by using more efficient and rapid OKSM indu-
cing animal models, live video imaging and constitutive
fluorescence markers for cell survival [2,7]. Nevertheless,
the findings by Di Stefano et al. present a new means for
cell type-specific robust reactivation of the endogenous
pluripotency network by OSKM.
Summarizing thoughts and future perspectives
These recent studies synergistically lead to a model in
which the critical rate-limiting factor to reestablishing
pluripotency in somatic cells is to rapidly breach
through the barrier of reactivating the endogenous pluri-
potency interconnected circuit (Figure 1). Once this
threshold is passed, pluripotency becomes an inevitable
outcome and hijacks somatic cell identity [9] (Figure 1b,
c). Some cells can achieve this randomly upon OSKM
induction with different probabilities [4]. One means to
allow nearly all cells to do this early is to reduce epigenetic
co-repressors, such as Mbd3, that are recruited by OSKM
in a counterproductive manner and hamper pluripotency
reactivation [2]. Another strategy is to use cell type-
specific boosters, such as C/EBPα, that achieve robust and
rapid reactivation of pluripotency by OSKM [5].
Further, these studies highlight the interplay between
transcription factor and chromatin changes when indu-
cing the complete epigenetic reprogramming that leads
to authentic pluripotency induction. While in OSKM-
triggered iPSC reprogramming, OSKM initiate the critical
secondary epigenetic events, recent studies have pointed
to what may be a global epigenetic change as an initial
trigger that can randomly lead to secondary transcrip-
tional reactivation of the endogenous pluripotency net-
work without exogenous transcription factor expression.
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molecule compound combinations, several of which target
epigenetic repressors, are sufficient to induce the pluripo-
tency transcriptional network in mouse fibroblasts [10].
Another recent sensational study reported the ability to
trigger acquisition of pluripotency in neonatal mouse cells
by transient exposure to low-pH conditions (with the
resulting cells termed ‘STAP’ cells) [6]. If confirmed, these
studies may underscore a ‘chicken-or-the-egg’ paradigm re-
garding the co-dominance between transcription factors
and chromatin landscape. Detailed understanding of the
interplay between these components is key to the molecular
understanding of cell reprogramming and lineage specifica-
tion trajectories.
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